UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC  20549
________________

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) November 1, 2019
COLGATE PALMOLIVE COMPANY
 (Exact name of registrant as specified in its charter)

Delaware
1-644
13-1815595
(State or Other Jurisdiction
of Incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)

300 Park Avenue, New York, New York 10022
(Address of Principal Executive Offices) (Zip Code)

Registrant’s telephone number, including area code (212) 310-2000

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class
  Trading Symbol(s)
 
Name of each exchange on which
registered
Common Stock, $1.00 par value
  CL
  New York Stock Exchange
0.500% Notes due 2026
  CL 26
  New York Stock Exchange
1.375% Notes due 2034
  CL 34
  New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02.    Results of Operations and Financial Condition.

On November 1, 2019, Colgate-Palmolive Company (the “Company”) issued a press release announcing its earnings for the quarter ended September 30, 2019.  This press release is attached as Exhibit 99 and is incorporated herein by reference.

The information in Item 2.02 of this Current Report is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section.  The information in Item 2.02 of this Current Report shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.


Item 9.01.     Financial Statements and Exhibits.

(d)     Exhibits.  The following exhibit is filed with this document:

Exhibit Number

99
Description

Press release, dated November 1, 2019, issued by Colgate-Palmolive Company

104
Cover Page Interactive Data File (embedded within the Inline eXtensible Business Reporting Language (Inline XBRL) document)
2

EXHIBIT INDEX


104
Cover Page Interactive Data File (embedded within the Inline eXtensible Business Reporting Language (Inline XBRL) document)
3

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
COLGATE-PALMOLIVE COMPANY
 
 
 
     
Date:   November 1, 2019
By:
/s/ Henning I Jakobsen
 
Name:   Henning I. Jakobsen
 
Title:     Chief Financial Officer


4
Exhibit 99

Colgate Announces 3rd Quarter 2019 Results

NEW YORK--(BUSINESS WIRE)--November 1, 2019--Colgate-Palmolive Company (NYSE:CL) today reported worldwide Net sales of $3,928 million in third quarter 2019, an increase of 2.0% versus third quarter 2018. Global unit volume increased 3.0%, pricing increased 1.5% and foreign exchange was negative 2.5%. Organic sales (Net sales excluding the impact of foreign exchange, acquisitions and divestments) increased 4.5%.

Net income and Diluted earnings per share in third quarter 2019 were $578 million and $0.67, respectively. Net income in third quarter 2019 included $36 million ($0.04 per diluted share) of aftertax charges resulting from the Company’s Global Growth and Efficiency Program and acquisition costs primarily related to the previously disclosed acquisition of the Laboratoires Filorga Cosmétiques ("Filorga") skin health business, which closed on September 19, 2019.

Net income and Diluted earnings per share in third quarter 2018 were $523 million and $0.60, respectively. Net income in third quarter 2018 included $102 million ($0.12 per diluted share) of aftertax charges resulting from the Global Growth and Efficiency Program and related to U.S. tax reform.

Excluding charges resulting from the Global Growth and Efficiency Program in both periods, acquisition costs in 2019 and the charge related to U.S. tax reform in 2018, Net income in third quarter 2019 was $614 million, a decrease of 2% versus third quarter 2018, and Diluted earnings per share in third quarter 2019 were $0.71, a decrease of 1% versus third quarter 2018.


Gross profit margin was 59.0% in third quarter 2019, even with third quarter 2018. Excluding charges resulting from the Global Growth and Efficiency Program in both periods, Gross profit margin was 59.0% in third quarter 2019, a decrease of 20 basis points versus the year ago quarter as higher raw and packaging material costs, which included foreign exchange transaction costs, were partially offset by cost savings from the Company’s funding-the-growth initiatives and higher pricing.

Selling, general and administrative expenses were 36.4% of Net sales in third quarter 2019 versus 35.6% of Net sales in third quarter 2018. Excluding charges resulting from the Global Growth and Efficiency Program in both periods, Selling, general and administrative expenses increased by 30 basis points versus the year ago quarter to 35.7% of Net sales in third quarter 2019 due to increased advertising investment, partially offset by lower overhead expenses, both as a percentage of Net sales. On an absolute basis, worldwide advertising investment increased 7% to $423 million versus $395 million in the year ago quarter.

Operating profit decreased to $856 million in third quarter 2019 compared to $874 million in third quarter 2018. Excluding charges resulting from the Global Growth and Efficiency Program in both periods and acquisition costs in 2019, Operating profit was $900 million in third quarter 2019, even with third quarter 2018. Operating profit margin was 21.8% in third quarter 2019 versus 22.7% in third quarter 2018. Excluding charges resulting from the Global Growth and Efficiency Program in both periods and acquisition costs in 2019, Operating profit margin was 22.9% in third quarter 2019, a decrease of 50 basis points versus the year ago quarter. This decrease in Operating profit margin was due to a decrease in Gross profit and an increase in Selling, general and administrative expenses, both as a percentage of Net sales.

Net cash provided by operations year to date was $2,163 million compared to $2,194 million in the comparable 2018 period. Working capital as a percentage of Net sales was negative 2.8% compared to negative 3.1% in the year ago period.


Noel Wallace, President and Chief Executive Officer, commented on the third quarter results, “We are pleased that our growth continued to accelerate this quarter, having achieved sequential improvement in organic sales growth for the fourth consecutive quarter. The strong 4.5% growth was again driven by both positive volume and higher pricing.

"We are very focused on sustaining this growth momentum by continuing to innovate in our core businesses, pursue adjacent categories and expand into new markets and channels. We also continue to invest behind our brands, with our advertising investment increasing in absolute dollars and as a percent to sales versus third quarter 2018.

“Colgate’s leadership of the global toothpaste market continued during the quarter with our global market share at 41.2% year to date. Our global leadership in manual toothbrushes also continued with Colgate’s global market share in that category at 31.6% year to date.”

Mr. Wallace continued, “As we look ahead, based on current spot rates, we continue to expect 2019 net sales to be flat to up low-single-digits, with organic sales now expected to be up between 3% and 4%, roughly in line with year-to-date growth.

“On a GAAP basis, based on current spot rates, we now expect a slight decline in gross margin and continue to expect a low-single-digit decline in earnings per share in 2019.

“Excluding charges resulting from the Global Growth and Efficiency Program in both 2018 and 2019, acquisition costs in 2019, the charge related to U.S. tax reform in 2018 and the benefit from a foreign tax matter in 2018, based on current spot rates, we now expect a slight decline in gross margin and continue to plan for increased advertising investment and a mid-single-digit decline in earnings per share.”


At 11:00 a.m. ET today, Colgate will host a conference call to elaborate on third quarter results. To access this call as a webcast, please go to Colgate’s website at http://www.colgatepalmolive.com.

The following are comments about divisional performance for third quarter 2019 versus the year ago period. See attached Geographic Sales Analysis Percentage Changes and Segment Information tables for additional information on divisional net sales and operating profit.

North America (22% of Company Sales)

North America Net sales increased 1.5% in third quarter 2019. Unit volume increased 0.5%, pricing increased 1.0% and foreign exchange was even with the year ago period. Organic sales for North America increased 1.5%.

Operating profit in North America decreased 4% in third quarter 2019 to $248 million, or 170 basis points to 28.5% of Net sales. This decrease in Operating profit as a percentage of Net sales was primarily due to a decrease in Gross profit, partially offset by a decrease in Selling, general and administrative expenses, both as a percentage of Net sales. This decrease in Gross profit was primarily due to higher raw and packaging material costs, partially offset by cost savings from the Company’s funding-the-growth initiatives. This decrease in Selling, general and administrative expenses was primarily due to lower overhead expenses.

In the U.S., Colgate's share of the toothpaste market is at 34.3% year to date. Successful products include Colgate Optic White Stain Fighter, Colgate Essentials with Charcoal and Colgate TotalSF toothpastes. In manual toothbrushes, Colgate maintained its brand market leadership in the U.S. with its market share in that category at 39.9% year to date, supported by the success of Colgate 360° and Colgate Gum Health manual toothbrushes.


Products succeeding in other categories include EltaMD foaming facial cleanser, EltaMD UV Clear facial sunscreen, PCA Skin Vitamin B3 Brightening Serum, Irish Spring 5-in-1 body wash, Fabuloso Complete liquid cleaner and Suavitel Complete fabric conditioner.

Latin America (23% of Company Sales)

Latin America Net sales increased 3.0% in third quarter 2019. Unit volume increased 4.5%, pricing increased 3.5% and foreign exchange was negative 5.0%. Volume gains were led by Brazil, Central America, Colombia and Mexico. Organic sales for Latin America increased 8.0%.

Operating profit in Latin America increased 6% in third quarter 2019 to $235 million, or 80 basis points to 26.7% of Net sales. This increase in Operating profit as a percentage of Net sales was primarily due to an increase in Gross profit, partially offset by an increase in Selling, general and administrative expenses, both as a percentage of Net sales. This increase in Gross profit was primarily due to cost savings from the Company’s funding-the-growth initiatives and higher pricing, partially offset by higher raw and packaging material costs, which included foreign exchange transaction costs. This increase in Selling, general and administrative expenses was due to increased advertising investment, partially offset by lower overhead expenses.

Colgate maintained its toothpaste leadership in Latin America during the quarter, with market share gains in Colombia, the Dominican Republic, Panama, Chile, El Salvador and Honduras. Products succeeding in the region include the relaunched Colgate Total 12, Colgate Natural Extracts, Colgate Periogard, Colgate Orthogard and elmex toothpastes. Colgate’s leadership in the manual toothbrush category continued in the region, supported by the success of Colgate Pro Cuidado, Colgate Ultra Soft and Colgate Bamboo manual toothbrushes.

Products succeeding in other categories include Colgate Total 12 and Colgate Periogard mouthwashes, Protex Pro-Hidrata and Palmolive Natureza Secreta bar soaps, Lady Speed Stick Clinical Complete and Speed Stick Clinical Complete deodorants, Suavitel Complete fabric conditioner, Axion dish liquid and Fabuloso Bleach Alternative liquid cleaner.


Europe (15% of Company Sales)

Europe Net sales decreased 5.0% in third quarter 2019. Unit volume increased 1.5%, pricing decreased 1.5% and foreign exchange was negative 5.0%. Volume gains in France, Spain and the United Kingdom were partially offset by volume declines in Germany. Organic sales for Europe were even with the year ago period. The results of operations of Filorga for the period from the acquisition date through September 30, 2019 were not material to the Company's consolidated results of operations and are not included in the Company's third quarter results.

Operating profit in Europe decreased 6% in third quarter 2019 to $153 million, or 10 basis points to 25.2% of Net sales. This decrease in Operating profit as a percentage of Net sales was due to a decrease in Gross profit, partially offset by a decrease in Selling, general and administrative expenses, both as a percentage of Net sales. This decrease in Gross Profit was primarily due to higher raw and packaging material costs and lower pricing, partially offset by cost savings from the Company’s funding-the-growth initiatives. This decrease in Selling, general and administrative expenses was primarily due to decreased advertising investment.

Colgate maintained its toothpaste leadership in Europe during the quarter, with market share gains in the United Kingdom, Italy, Spain, Greece, the Netherlands and Denmark. Products succeeding in oral care include the relaunched Colgate Total, Colgate Max White Expert Anti-Stain, Colgate Max White Charcoal, Colgate Natural Extracts Charcoal and elmex toothpastes, Colgate Slim Soft Advanced manual toothbrush and meridol mouthwash.

Products succeeding in other categories include Sanex pump body lotions, Palmolive Clay and Sanex body washes, Ajax Boost liquid cleaner and Soupline fabric conditioner.


Asia Pacific (18% of Company Sales)

Asia Pacific Net sales increased 2.5% during third quarter 2019. Unit volume increased 2.0%, pricing increased 1.0% and foreign exchange was negative 0.5%. Volume gains in the Philippines, Australia, India, New Zealand and the Greater China region were partially offset by volume declines in Malaysia. Organic sales for Asia Pacific increased 3.0%.

Operating profit in Asia Pacific increased 1% in third quarter 2019 to $193 million, while as a percentage of Net sales it decreased 40 basis points to 28.0% of Net sales. This decrease in Operating profit as a percentage of Net sales was primarily due to an increase in Selling, general and administrative expenses, partially offset by an increase in Gross profit, both as a percentage of Net sales. This increase in Gross Profit was primarily due to cost savings from the Company’s funding-the-growth initiatives and higher pricing, partially offset by higher raw and packaging material costs. This increase in Selling, general and administrative expenses was due to higher overhead expenses and increased advertising investment.

Colgate maintained its toothpaste leadership in the Asia Pacific region during the quarter with market share gains in the Philippines, New Zealand and Pakistan. Products succeeding in oral care include Colgate Maximum Cavity Protection with Amino Power, Colgate Charcoal Clean, Colgate Miracle Repair, Colgate Vedshakti and elmex toothpastes and Colgate Cushion Clean manual toothbrush.

Products succeeding in other categories include Palmolive Men With Natural Charcoal bar soap, Palmolive Luminous Oils shower gel and liquid hand soap and Ajax Eco Clean multipurpose biodegradable wipes.

Africa/Eurasia (6% of Company Sales)

Africa/Eurasia Net sales increased 5.0% during third quarter 2019. Unit volume increased 3.0%, pricing increased 4.0% and foreign exchange was negative 2.0%. The Company's new joint venture in Nigeria contributed 1.0% to Net sales and unit volume growth. Volume gains in Russia, the Gulf States and Kenya were partially offset by volume declines in South Africa. Organic sales and organic unit volume for Africa/Eurasia increased 6.0% and 2.0%, respectively.


Operating profit in Africa/Eurasia increased 17% in third quarter 2019 to $48 million, or 200 basis points to 19.4% of Net sales. This increase in Operating profit as a percentage of Net sales was primarily due to an increase in Gross profit, partially offset by an increase in Selling, general and administrative expenses, both as a percentage of Net sales. This increase in Gross profit was primarily due to cost savings from the Company’s funding-the-growth initiatives and higher pricing, partially offset by higher raw and packaging material costs, which included foreign exchange transaction costs. This increase in Selling, general and administrative expenses was due to higher overhead expenses and increased advertising investment.

Colgate maintained its toothpaste leadership in Africa/Eurasia during the quarter, with market share gains in Turkey, Kazakhstan, Morocco, Jordan and Bahrain. Successful products contributing to sales in the region include the relaunched Colgate Total 12, Colgate Optic White Charcoal, Colgate Safe Whitening and meridol toothpastes, and Palmolive Micellar Care shower gel and bar soap.

Hill's Pet Nutrition (16% of Company Sales)

Hill’s Net sales increased 8.5% during third quarter 2019. Unit volume increased 6.5%, pricing increased 3.5% and foreign exchange was negative 1.5%. Volume gains in the United States and Western Europe were partially offset by volume declines in South Africa. Hill’s organic sales increased 10.0%.

Hill’s Operating profit in third quarter 2019 increased 4% to $169 million, while as a percentage of Net sales it decreased 130 basis points to 26.7% of Net sales. This decrease in Operating profit as a percentage of Net sales was primarily due to a decrease in Gross profit and an increase in Selling, general and administrative expenses, both as a percentage of Net sales. This decrease in Gross profit was primarily due to higher raw and packaging material costs, partially offset by cost savings from the Company’s funding-the-growth initiatives and higher pricing. This increase in Selling, general and administrative expenses was due to increased advertising investment, partially offset by lower overhead expenses.


Successful products contributing to sales in the United States include the relaunched Hill’s Science Diet (with upgraded recipes, improved kibble shapes and redesigned package graphics) and Hill's Prescription Diet Gastrointestinal Biome.

Successful products contributing to sales internationally include Hill’s Prescription Diet Stews and the relaunched Hill’s Science Diet.

***

About Colgate-Palmolive: Colgate-Palmolive is a leading global consumer products company, focused on Oral Care, Personal Care, Home Care and Pet Nutrition. With more than 34,000 people and its products sold in over 200 countries and territories, Colgate is known for household names such as Colgate, Palmolive, elmex, Tom’s of Maine, Sorriso, Speed Stick, Lady Speed Stick, Softsoap, Irish Spring, Protex, Sanex, Filorga, EltaMD, PCA Skin, Ajax, Axion, Fabuloso, Soupline and Suavitel, as well as Hill’s Science Diet and Hill’s Prescription Diet. The Company is also recognized for its leadership and innovation in promoting environmental sustainability and community wellbeing, including its achievements in saving water, reducing waste, promoting recyclability and improving the oral health of children through its Bright Smiles, Bright Futures program, which has reached more than one billion children since 1991. For more information about Colgate’s global business and how the Company is building a future to smile about, visit http://www.colgatepalmolive.com.


Market Share Information

Management uses market share information as a key indicator to monitor business health and performance. References to market share in this press release are based on a combination of consumption and market share data provided by third-party vendors, primarily Nielsen, and internal estimates. All market share references represent the percentage of the dollar value of sales of our products, relative to all product sales in the category in the countries in which the Company competes and purchases data (excluding Venezuela from all periods).

Market share data is subject to limitations on the availability of up-to-date information. In particular, market share data is currently not generally available for certain retail channels, such as eCommerce or certain discounters. The Company measures year-to-date market shares from January 1 of the relevant year through the most recent period for which market share data is available, which typically reflects a lag time of one or two months. The Company believes that the third-party vendors it uses to provide data are reliable, but it has not verified the accuracy or completeness of the data or any assumptions underlying the data. In addition, market share information reported by the Company may be different from market share information reported by other companies due to differences in category definitions, the use of data from different countries, internal estimates and other factors.

Cautionary Statement on Forward-Looking Statements

This press release and the related webcast may contain forward-looking statements (as that term is defined in the U.S. Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission (SEC) in its rules, regulations and releases) that set forth anticipated results based on management’s current plans and assumptions. Such statements may relate, for example, to sales or volume growth, net selling price increases, organic sales growth, profit or profit margin growth, earnings per share levels, financial goals, the impact of foreign exchange volatility, cost-reduction plans including the Global Growth and Efficiency Program, tax rates, U.S. tax reform, new product introductions, commercial investment levels, acquisitions, divestitures, share repurchases, or legal or tax proceedings, among other matters. These statements are made on the basis of the Company’s views and assumptions as of this time and the Company undertakes no obligation to update these statements whether as a result of new information, future events or otherwise, except as required by law or by the rules and regulations of the SEC. Moreover, the Company does not nor does any other person assume responsibility for the accuracy and completeness of these statements. The Company cautions investors that any such forward-looking statements are not guarantees of future performance and that actual events or results may differ materially from those statements. For more information about factors that could impact the Company’s business and cause actual results to differ materially from forward-looking statements, investors should refer to the Company’s filings with the SEC (including, but not limited to, the information set forth under the captions “Risk Factors” and “Cautionary Statement on Forward-Looking Statements” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018 and subsequent Quarterly Reports on Form 10-Q). Copies of these filings may be obtained upon request from the Company’s Investor Relations Department or on the Company’s website at http://www.colgatepalmolive.com.


Non-GAAP Financial Measures

The following provides information regarding the non-GAAP financial measures used in this earnings release and/or the related webcast:

This release discusses Net sales growth (GAAP) and organic sales growth, which is Net sales growth excluding the impact of foreign exchange, acquisitions and divestments (non-GAAP). Management believes the organic sales growth measure provides investors and analysts with useful supplemental information regarding the Company’s underlying sales trends by presenting sales growth excluding the external factor of foreign exchange as well as the impact from acquisitions and divestments. See “Geographic Sales Analysis Percentage Changes” for the three and nine months ended September 30, 2019 vs. 2018 included with this release for a comparison of organic sales growth to Net sales growth in accordance with GAAP.


To supplement Colgate’s Condensed Consolidated Statements of Income presented in accordance with GAAP, the Company has disclosed non-GAAP measures of operating results that exclude certain items. Worldwide Gross profit, Gross profit margin, Selling, general and administrative expenses, Selling, general and administrative expenses as a percentage of Net sales, Other (income) expense, net, Operating profit, Operating profit margin, Non-service related postretirement costs, Effective income tax rate, Net income attributable to Colgate-Palmolive Company and Diluted earnings per common share are discussed both as reported (on a GAAP basis) and excluding charges resulting from the Global Growth and Efficiency Program and, as applicable, acquisition costs in 2019, the benefit from a foreign tax matter in 2018 and the charge related to U.S. tax reform in 2018 (non-GAAP). These non-GAAP financial measures exclude items that, either by their nature or amount, management would not expect to occur as part of the Company’s normal business on a regular basis, such as restructuring charges, charges for certain litigation and tax matters, gains and losses from certain divestitures and certain unusual, non-recurring items. Investors and analysts use these financial measures in assessing the Company’s business performance, and management believes that presenting these financial measures on a non-GAAP basis provides them with useful supplemental information to enhance their understanding of the Company’s underlying business performance and trends. These non-GAAP financial measures also enhance the ability to compare period-to-period financial results. See “Non-GAAP Reconciliations” for the three and nine months ended September 30, 2019 and 2018 included with this release for a reconciliation of these financial measures to the related GAAP measures.

The Company uses these financial measures internally in its budgeting process, to evaluate segment and overall operating performance and as factors in determining compensation. While the Company believes that these financial measures are useful in evaluating the Company’s underlying business performance and trends, this information should be considered as supplemental in nature and is not meant to be considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP. In addition, these non-GAAP financial measures may not be the same as similar measures presented by other companies.


The Company defines free cash flow before dividends as Net cash provided by operations less Capital expenditures. As management uses this measure to evaluate the Company’s ability to satisfy current and future obligations, repurchase stock, pay dividends and fund future business opportunities, the Company believes that it provides useful information to investors. Free cash flow before dividends is not a measure of cash available for discretionary expenditures since the Company has certain non-discretionary obligations such as debt service that are not deducted from the measure. Free cash flow before dividends is a non-GAAP measure and may not be comparable to similarly titled measures reported by other companies. See “Condensed Consolidated Statements of Cash Flows” for the nine months ended September 30, 2019 and 2018 for a comparison of free cash flow before dividends to Net cash provided by operations as reported in accordance with GAAP.

(See attached tables for third quarter results.)


Table 1


Colgate-Palmolive Company


 


Condensed Consolidated Statements of Income


 


For the Three Months Ended September 30, 2019 and 2018


 


(Dollars in Millions Except Per Share Amounts) (Unaudited)


 


 

 

2019

 

2018


 

 

 

 

 


Net sales

 

$

 

3,928

 

 

$

 

3,845

 


 

 

 

 

 


Cost of sales

 

 

1,612

 

 

 

1,576

 


 

 

 

 

 


Gross profit

 

 

2,316

 

 

 

2,269

 


 

 

 

 

 


Gross profit margin

 

 

59.0

%

 

 

59.0

%


 

 

 

 

 


Selling, general and administrative expenses

 

 

1,429

 

 

 

1,369

 


 

 

 

 

 


Other (income) expense, net

 

 

31

 

 

 

26

 


 

 

 

 

 


Operating profit

 

 

856

 

 

 

874

 


 

 

 

 

 


Operating profit margin

 

 

21.8

%

 

 

22.7

%


 

 

 

 

 


Non-service related postretirement costs

 

 

27

 

 

 

18

 


 

 

 

 

 


Interest (income) expense, net

 

 

35

 

 

 

36

 


 

 

 

 

 


Income before income taxes

 

 

794

 

 

 

820

 


 

 

 

 

 


Provision for income taxes

 

 

167

 

 

 

258

 


 

 

 

 

 


Effective tax rate

 

 

21.0

%

 

 

31.5

%


 

 

 

 

 


Net income including noncontrolling interests

 

 

627

 

 

 

562

 


 

 

 

 

 


Less: Net income attributable to noncontrolling interests

 

 

49

 

 

 

39

 


 

 

 

 

 


Net income attributable to Colgate-Palmolive Company

 

$

 

578

 

 

$

 

523

 


 

 

 

 

 


Earnings per common share

 

 

 

 


Basic

 

$

 

0.67

 

 

$

 

0.60

 


Diluted

 

$

 

0.67

 

 

$

 

0.60

 


 

 

 

 

 


Average common shares outstanding

 

 

 

 


Basic

 

 

858.7

 

 

 

868.8

 


Diluted

 

 

861.2

 

 

 

871.1

 



Table 2


Colgate-Palmolive Company


 


Condensed Consolidated Statements of Income


 


For the Nine Months Ended September 30, 2019 and 2018


 


(Dollars in Millions Except Per Share Amounts) (Unaudited)


 

 

 

 

 


 

 

2019

 

2018


 

 

 

 

 


Net sales

 

$

 

11,678

 

 

$

 

11,733

 


 

 

 

 

 


Cost of sales

 

 

4,767

 

 

 

4,755

 


 

 

 

 

 


Gross profit

 

 

6,911

 

 

 

6,978

 


 

 

 

 

 


Gross profit margin

 

 

59.2

%

 

 

59.5

%


 

 

 

 

 


Selling, general and administrative expenses

 

 

4,163

 

 

 

4,061

 


 

 

 

 

 


Other (income) expense, net

 

 

125

 

 

 

114

 


 

 

 

 

 


Operating profit

 

 

2,623

 

 

 

2,803

 


 

 

 

 

 


Operating profit margin

 

 

22.5

%

 

 

23.9

%


 

 

 

 

 


Non-service related postretirement costs

 

 

79

 

 

 

65

 


 

 

 

 

 


Interest (income) expense, net

 

 

113

 

 

 

106

 


 

 

 

 

 


Income before income taxes

 

 

2,431

 

 

 

2,632

 


 

 

 

 

 


Provision for income taxes

 

 

586

 

 

 

717

 


 

 

 

 

 


Effective tax rate

 

 

24.1

%

 

 

27.2

%


 

 

 

 

 


Net income including noncontrolling interests

 

 

1,845

 

 

 

1,915

 


 

 

 

 

 


Less: Net income attributable to noncontrolling interests

 

 

121

 

 

 

121

 


 

 

 

 

 


Net income attributable to Colgate-Palmolive Company

 

$

 

1,724

 

 

$

 

1,794

 


 

 

 

 

 


Earnings per common share

 

 

 

 


Basic(1)

 

$

 

2.00

 

 

$

 

2.06

 


Diluted(1)

 

$

 

2.00

 

 

$

 

2.05

 


 

 

 

 

 


Average common shares outstanding

 

 

 

 


Basic

 

 

860.1

 

 

 

871.9

 


Diluted

 

 

862.4

 

 

 

875.0

 


Note:

(1) Basic and diluted earnings per share are computed independently for each quarter and any year-to-date period presented. As a result of changes in shares outstanding during the year and rounding, the sum of the quarters’ earnings per share may not necessarily equal the earnings per share for any year-to-date period.


Table 3

Colgate-Palmolive Company

 

Condensed Consolidated Balance Sheets

 

As of September 30, 2019, December 31, 2018 and September 30, 2018

 

(Dollars in Millions) (Unaudited)

 

 

 

 

 

 

 

 

 

September 30,

 

December 31,

 

September 30,

 

 

2019

 

2018

 

2018

Cash and cash equivalents

 

$

 

948

 

 

$

 

726

 

 

$

 

841

 

Receivables, net

 

 

1,495

 

 

 

1,400

 

 

 

1,532

 

Inventories

 

 

1,371

 

 

 

1,250

 

 

 

1,245

 

Other current assets

 

 

535

 

 

 

417

 

 

 

523

 

Property, plant and equipment, net

 

 

3,689

 

 

 

3,881

 

 

 

3,871

 

Other assets, including goodwill and intangibles

 

 

6,988

 

 

 

4,487

 

 

 

4,559

 

Total assets

 

$

 

15,026

 

 

$

 

12,161

 

 

$

 

12,571

 

 

 

 

 

 

 

 

Total debt

 

$

 

8,151

 

 

$

 

6,366

 

 

$

 

6,604

 

Other current liabilities

 

 

3,726

 

 

 

3,329

 

 

 

3,662

 

Other non-current liabilities

 

 

2,975

 

 

 

2,269

 

 

 

2,373

 

Total liabilities

 

 

14,852

 

 

 

11,964

 

 

 

12,639

 

Total Colgate-Palmolive Company shareholders’ equity

 

 

(324

)

 

 

(102

)

 

 

(430

)

Noncontrolling interests

 

 

498

 

 

 

299

 

 

 

362

 

Total liabilities and equity

 

$

 

15,026

 

 

$

 

12,161

 

 

$

 

12,571

 

 

 

 

 

 

 

 

Supplemental Balance Sheet Information

 

 

 

 

 

 

Debt less cash, cash equivalents and marketable securities(1)

 

$

 

7,094

 

 

$

 

5,630

 

 

$

 

5,643

 

Working capital % of sales

 

 

(2.8

)%

 

 

(1.7

)%

 

 

(3.1

)%

Note:

(1) Marketable securities of $109, $10 and $120 as of September 30, 2019, December 31, 2018 and September 30, 2018, respectively, are included in Other current assets.

Table 4

Colgate-Palmolive Company

 

Condensed Consolidated Statements of Cash Flows

 

For the Nine Months Ended September 30, 2019 and 2018

 

(Dollars in Millions) (Unaudited)

 

 

 

 

 

 

 

2019

 

2018

Operating Activities

 

 

 

 

Net income including noncontrolling interests

 

$

 

1,845

 

 

$

 

1,915

 

Adjustments to reconcile Net income including noncontrolling interests to Net cash provided by operations:

 

 

Depreciation and amortization

 

 

386

 

 

 

385

 

Restructuring and termination benefits, net of cash

 

 

11

 

 

 

(20

)

Stock-based compensation expense

 

 

83

 

 

 

97

 

Charge for U.S. tax reform

 

 

 

 

80

 

Deferred income taxes

 

 

79

 

 

 

78

 

Voluntary benefit plan contributions

 

 

(113

)

 

 

(67

)

Cash effects of changes in:

 

 

 

 

Receivables

 

 

(65

)

 

 

(196

)

Inventories

 

 

(69

)

 

 

(36

)

Accounts payable and other accruals

 

 

(52

)

 

 

13

 

Other non-current assets and liabilities

 

 

58

 

 

 

(55

)

Net cash provided by operations

 

 

2,163

 

 

 

2,194

 

 

 

 

 

 

Investing Activities

 

 

 

 

Capital expenditures

 

 

(226

)

 

 

(321

)

Purchases of marketable securities and investments

 

 

(152

)

 

 

(159

)

Proceeds from sale of marketable securities and investments

 

 

14

 

 

 

28

 

Payment for acquisitions, net of cash acquired

 

 

(1,711

)

 

 

(728

)

Other

 

 

 

 

6

 

Net cash used in investing activities

 

 

(2,075

)

 

 

(1,174

)

 

 

 

 

 

Financing Activities

 

 

 

 

Principal payments on debt

 

 

(4,184

)

 

 

(5,478

)

Proceeds from issuance of debt

 

 

6,008

 

 

 

5,536

 

Dividends paid

 

 

(1,140

)

 

 

(1,122

)

Purchases of treasury shares

 

 

(1,024

)

 

 

(956

)

Proceeds from exercise of stock options

 

 

490

 

 

 

319

 

Net cash provided by (used in) financing activities

 

 

150

 

 

 

(1,701

)

 

 

 

 

 

Effect of exchange rate changes on Cash and cash equivalents

 

 

(16

)

 

 

(13

)

Net increase (decrease) in Cash and cash equivalents

 

 

222

 

 

 

(694

)

Cash and cash equivalents at beginning of the period

 

 

726

 

 

 

1,535

 

Cash and cash equivalents at end of the period

 

$

 

948

 

 

$

 

841

 

 

 

 

 

 

Supplemental Cash Flow Information

 

 

 

 

Free cash flow before dividends (Net cash provided by operations less Capital expenditures)

 

 

 

 

Net cash provided by operations

 

$

 

2,163

 

 

$

 

2,194

 

Less: Capital expenditures

 

 

(226

)

 

 

(321

)

Free cash flow before dividends

 

$

 

1,937

 

 

$

 

1,873

 

 

 

 

 

 

Income taxes paid

 

$

 

669

 

 

$

 

655

 


Table 5

Colgate-Palmolive Company

 

Segment Information

 

For the Three and Nine Months Ended September 30, 2019 and 2018

 

(Dollars in Millions) (Unaudited)

 

 

 

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

 

2019

 

2018

 

2019

 

2018

Net Sales

 

 

 

 

 

 

 

 

Oral, Personal and Home Care

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

North America

 

$

 

869

 

 

$

 

858

 

 

$

 

2,568

 

 

$

 

2,509

 

Latin America

 

 

881

 

 

 

856

 

 

 

2,700

 

 

 

2,718

 

Europe

 

 

607

 

 

 

640

 

 

 

1,798

 

 

 

1,908

 

Asia Pacific

 

 

690

 

 

 

673

 

 

 

2,035

 

 

 

2,106

 

Africa/Eurasia

 

 

248

 

 

 

236

 

 

 

732

 

 

 

734

 

 

 

 

 

 

 

 

 

 

Total Oral, Personal and Home Care

 

 

3,295

 

 

 

3,263

 

 

 

9,833

 

 

 

9,975

 

 

 

 

 

 

 

 

 

 

Pet Nutrition

 

 

633

 

 

 

582

 

 

 

1,845

 

 

 

1,758

 

 

 

 

 

 

 

 

 

 

Total Net Sales

 

$

 

3,928

 

 

$

 

3,845

 

 

$

 

11,678

 

 

$

 

11,733

 

 

 

 

 

 

 

 

 

 









 

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

 

2019

 

2018

 

2019

 

2018

Operating Profit

 

 

 

 

 

 

 

 

Oral, Personal and Home Care

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

North America

 

$

 

248

 

 

$

 

259

 

 

$

 

750

 

 

$

 

780

 

Latin America

 

 

235

 

 

 

222

 

 

 

718

 

 

 

757

 

Europe

 

 

153

 

 

 

162

 

 

 

452

 

 

 

480

 

Asia Pacific

 

 

193

 

 

 

191

 

 

 

557

 

 

 

620

 

Africa/Eurasia

 

 

48

 

 

 

41

 

 

 

141

 

 

 

133

 

 

 

 

 

 

 

 

 

 

Total Oral, Personal and Home Care

 

 

877

 

 

 

875

 

 

 

2,618

 

 

 

2,770

 

 

 

 

 

 

 

 

 

 

Pet Nutrition

 

 

169

 

 

 

163

 

 

 

501

 

 

 

492

 

Corporate(1)

 

 

(190

)

 

 

(164

)

 

 

(496

)

 

 

(459

)

 

 

 

 

 

 

 

 

 

Total Operating Profit

 

$

 

856

 

 

$

 

874

 

 

$

 

2,623

 

 

$

 

2,803

 

Note:

(1) Corporate operations include costs related to stock options and restricted stock units, research and development costs, Corporate overhead costs, restructuring and related implementation costs and gains and losses on sales of non-core product lines and assets.

 
Corporate Operating profit (loss) for the three months ended September 30, 2019 and 2018 includes charges of $26 and $25, respectively, related to the Global Growth and Efficiency Program. Corporate Operating profit (loss) for the three months ended September 30, 2019 includes costs of $18 related to acquisitions.

 
Corporate Operating profit (loss) for the nine months ended September 30, 2019 and 2018 includes charges of $94 and $107, respectively, related to the Global Growth and Efficiency Program. Corporate Operating profit (loss) for the nine months ended September 30, 2019 includes costs of $18 related to acquisitions.

Table 6

Colgate-Palmolive Company

 

Geographic Sales Analysis Percentage Changes

 

For the Three Months Ended September 30, 2019 vs. 2018

 

(Unaudited)

 

 

 

 

 

 

 

 

COMPONENTS OF SALES CHANGE

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Pricing

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Coupons

 

 

 

 

Sales

 

 

 

 

 

 

 

 

 

Consumer &

 

 

 

 

Change

 

Organic

 

As Reported

 

Organic

 

Ex-Divested

 

Trade

 

Foreign

Region

 

As Reported

 

Sales Change

 

Volume(1)

 

Volume

 

Volume

 

Incentives

 

Exchange

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Company(1)

 

2.0

%

 

4.5

%

 

3.0

%

 

3.0

%

 

3.0

%

 

1.5

%

 

(2.5

)%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Europe

 

(5.0

)%

 

%

 

1.5

%

 

1.5

%

 

1.5

%

 

(1.5

)%

 

(5.0

)%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Latin America

 

3.0

%

 

8.0

%

 

4.5

%

 

4.5

%

 

4.5

%

 

3.5

%

 

(5.0

)%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Asia Pacific

 

2.5

%

 

3.0

%

 

2.0

%

 

2.0

%

 

2.0

%

 

1.0

%

 

(0.5

)%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Africa/Eurasia(1)

 

5.0

%

 

6.0

%

 

3.0

%

 

2.0

%

 

3.0

%

 

4.0

%

 

(2.0

)%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total International

 

1.0

%

 

4.5

%

 

3.0

%

 

3.0

%

 

3.0

%

 

1.5

%

 

(3.5

)%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

North America

 

1.5

%

 

1.5

%

 

0.5

%

 

0.5

%

 

0.5

%

 

1.0

%

 

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total CP Products

 

1.0

%

 

3.5

%

 

2.0

%

 

2.0

%

 

2.0

%

 

1.5

%

 

(2.5

)%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Hill’s

 

8.5

%

 

10.0

%

 

6.5

%

 

6.5

%

 

6.5

%

 

3.5

%

 

(1.5

)%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Emerging Markets(2)

 

3.0

%

 

6.0

%

 

3.0

%

 

3.0

%

 

3.0

%

 

3.0

%

 

(3.0

)%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Developed Markets

 

1.5

%

 

3.5

%

 

3.0

%

 

3.0

%

 

3.0

%

 

0.5

%

 

(2.0

)%

Notes:

(1) The impact of the Nigeria joint venture on as reported volume was 0% for Total Company and 1.0% for the Africa/Eurasia region.

(2) Emerging Markets include Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe.

Table 7

Colgate-Palmolive Company

 

Geographic Sales Analysis Percentage Changes

 

For the Nine Months Ended September 30, 2019 vs. 2018

 

(Unaudited)

 

 

 

 

 

 

 

 

COMPONENTS OF SALES CHANGE

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Pricing

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Coupons

 

 

 

 

Sales

 

 

 

 

 

 

 

 

 

Consumer &

 

 

 

 

Change

 

Organic

 

As Reported

 

Organic

 

Ex-Divested

 

Trade

 

Foreign

Region

 

As Reported

 

Sales Change

 

Volume(1)

 

Volume

 

Volume

 

Incentives

 

Exchange

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Company(1)

 

(0.5

)%

 

3.5

%

 

1.5

%

 

1.5

%

 

1.5

%

 

2.0

%

 

(4.0

)%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Europe

 

(6.0

)%

 

0.5

%

 

1.0

%

 

1.0

%

 

1.0

%

 

(0.5

)%

 

(6.5

)%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Latin America

 

(0.5

)%

 

7.0

%

 

3.0

%

 

3.0

%

 

3.0

%

 

4.0

%

 

(7.5

)%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Asia Pacific

 

(3.5

)%

 

%

 

(0.5

)%

 

(0.5

)%

 

(0.5

)%

 

0.5

%

 

(3.5

)%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Africa/Eurasia(1)

 

(0.5

)%

 

7.5

%

 

2.0

%

 

1.5

%

 

2.0

%

 

6.0

%

 

(8.5

)%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total International

 

(2.5

)%

 

3.5

%

 

1.5

%

 

1.5

%

 

1.5

%

 

2.0

%

 

(6.0

)%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

North America

 

2.5

%

 

2.5

%

 

1.5

%

 

1.5

%

 

1.5

%

 

1.0

%

 

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total CP Products

 

(1.5

)%

 

3.0

%

 

1.5

%

 

1.5

%

 

1.5

%

 

1.5

%

 

(4.5

)%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Hill’s

 

5.0

%

 

7.0

%

 

3.5

%

 

3.5

%

 

3.5

%

 

3.5

%

 

(2.0

)%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Emerging Markets(2)

 

(1.5

)%

 

4.5

%

 

1.5

%

 

1.5

%

 

1.5

%

 

3.0

%

 

(6.0

)%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Developed Markets

 

0.5

%

 

3.0

%

 

2.0

%

 

2.0

%

 

2.0

%

 

1.0

%

 

(2.5

)%

Notes:

(1) The impact of the Nigeria joint venture on as reported volume was 0% for Total Company and 0.5% for the Africa/Eurasia region.

(2) Emerging Markets include Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe.

Table 8

Colgate-Palmolive Company

 

Non-GAAP Reconciliations

 

For the Three Months Ended September 30, 2019 and 2018

 

(Dollars in Millions Except Per Share Amounts) (Unaudited)

 

Gross Profit

 

 

 

 

 

 

 

 

 

2019

 

2018

 

 

Gross profit, GAAP

 

 

 

 

 

 

 

$

 

2,316

 

 

$

 

2,269

 

 

 

Global Growth and Efficiency Program

 

 

 

 

 

 

 

 

1

 

 

 

8

 

 

 

Gross profit, non-GAAP

 

 

 

 

 

 

 

$

 

2,317

 

 

$

 

2,277

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basis Point

Gross Profit Margin

 

 

 

 

 

 

 

2019

 

2018

 

Change

Gross profit margin, GAAP

 

 

 

 

 

 

 

 

59.0

%

 

 

59.0

%

 

 

Global Growth and Efficiency Program

 

 

 

 

 

 

 

%

 

 

0.2

%

 

 

Gross profit margin, non-GAAP

 

 

 

 

 

 

 

 

59.0

%

 

 

59.2

%

 

 

(20

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, General and Administrative Expenses

 

 

 

 

 

2019

 

2018

 

 

Selling, general and administrative expenses, GAAP

 

 

 

 

$

 

1,429

 

 

$

 

1,369

 

 

 

Global Growth and Efficiency Program

 

 

 

 

 

 

 

 

(28

)

 

 

(9

)

 

 

Selling, general and administrative expenses, non-GAAP

 

$

 

1,401

 

 

$

 

1,360

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basis Point

Selling, General and Administrative Expenses as a Percentage of Net Sales

 

2019

 

2018

 

Change

Selling, general and administrative expenses as a percentage of Net sales, GAAP

 

 

36.4

%

 

 

35.6

%

 

 

80

 

Global Growth and Efficiency Program

 

 

 

 

 

 

 

 

(0.7

)%

 

 

(0.2

)%

 

 

Selling, general and administrative expenses as a percentage of Net sales, non-GAAP

 

35.7

%

 

 

35.4

%

 

 

30

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other (Income) Expense, Net

 

 

 

 

 

 

 

2019

 

2018

 

 

Other (income) expense, net, GAAP

 

 

 

 

$

 

31

 

 

$

 

26

 

 

 

Global Growth and Efficiency Program

 

 

 

 

 

3

 

 

 

(8

)

 

 

Acquisition costs

 

 

 

 

 

(18

)

 

 

 

 

Other (income) expense, net, non-GAAP

 

 

 

 

$

 

16

 

 

$

 

18

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating Profit

 

 

 

 

 

 

 

 

 

2019

 

2018

 

% Change

Operating profit, GAAP

 

 

 

 

$

 

856

 

 

$

 

874

 

 

 

(2

)%

Global Growth and Efficiency Program

 

 

 

 

 

26

 

 

 

25

 

 

 

Acquisition costs

 

 

 

 

 

18

 

 

 

 

 

Operating profit, non-GAAP

 

 

 

 

$

 

900

 

 

$

 

899

 

 

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basis Point

Operating Profit Margin

 

 

 

 

 

 

 

2019

 

2018

 

Change

Operating profit margin, GAAP

 

 

 

 

 

 

 

 

21.8

%

 

 

22.7

%

 

 

(90

)

Global Growth and Efficiency Program

 

 

 

 

 

 

 

 

0.7

%

 

 

0.7

%

 

 

Acquisition costs

 

 

 

 

 

0.4

%

 

%

 

 

Operating profit margin, non-GAAP

 

 

 

 

 

 

 

 

22.9

%

 

 

23.4

%

 

 

(50

)

 

 

Non-Service Related Postretirement Costs

 

 

 

2019

 

2018

 

 

Non-service related postretirement costs, GAAP

 

 

 

$

 

27

 

 

$

 

18

 

 

 

Global Growth and Efficiency Program

 

(1

)

 

 

(1

)

 

 

Non-service related postretirement costs, non-GAAP

 

 

 

$

 

26

 

 

$

 

17

 

 

 


Table 8

Continued

Colgate-Palmolive Company

 

Non-GAAP Reconciliations

 

For the Three Months Ended September 30, 2019 and 2018

 

(Dollars in Millions Except Per Share Amounts) (Unaudited)

 

 

 

 

 

 

 

2019

 

Income Before
Income Taxes

 

Provision For
Income Taxes(1)

 

Net Income
Including
Noncontrolling
Interests

 

Net Income
Attributable To
Colgate-Palmolive
Company

 

Effective
Income
Tax Rate(2)

 

Diluted
Earnings
Per Share

As Reported GAAP

$

 

794

 

 

$

 

167

 

 

$

 

627

 

 

$

 

578

 

 

21.0

%

 

$

 

0.67

 

Global Growth and Efficiency Program

 

27

 

 

 

5

 

 

 

22

 

 

 

22

 

 

(0.1

)%

 

 

0.03

 

Acquisition costs

18

 

 

 

4

 

 

 

14

 

 

 

14

 

 

0.1

%

 

0.01

 

Non-GAAP

$

 

839

 

 

$

 

176

 

 

$

 

663

 

 

$

 

614

 

 

21.0

%

 

$

 

0.71

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2018

 

Income Before
Income Taxes

 

Provision For
Income Taxes(1)

 

Net Income
Including
Noncontrolling
Interests

 

Net Income
Attributable To
Colgate-Palmolive
Company

 

Effective
Income
Tax Rate(2)

 

Diluted
Earnings
Per Share

As Reported GAAP

$

 

820

 

 

$

 

258

 

 

$

 

562

 

 

$

 

523

 

 

31.5

%

 

$

 

0.60

 

Global Growth and Efficiency Program

 

26

 

 

 

4

 

 

 

22

 

 

 

22

 

 

(0.5

)%

 

 

0.02

 

U.S. tax reform

 

 

 

(80

)

 

 

80

 

 

 

80

 

 

(9.5

)%

 

 

0.10

 

Non-GAAP

$

 

846

 

 

$

 

182

 

 

$

 

664

 

 

$

 

625

 

 

21.5

%

 

$

 

0.72

 

The impact of non-GAAP adjustments may not necessarily equal the difference between “GAAP” and “non-GAAP” as a result of rounding.
Notes:
(1) The income tax effect on non-GAAP items is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.

 

(2) The impact of non-GAAP items on the Company’s effective tax rate represents the difference in the effective tax rate calculated with and without the non-GAAP adjustment on Income before income taxes and Provision for income taxes.


Table 9

Colgate-Palmolive Company

 

Non-GAAP Reconciliations

 

For the Nine Months Ended September 30, 2019 and 2018

 

(Dollars in Millions Except Per Share Amounts) (Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross Profit

 

 

 

 

 

 

 

 

 

2019

 

2018

 

 

Gross profit, GAAP

 

 

 

 

 

 

 

$

 

6,911

 

 

$

 

6,978

 

 

 

Global Growth and Efficiency Program

 

 

 

 

 

 

 

 

9

 

 

 

19

 

 

 

Gross profit, non-GAAP

 

 

 

 

 

 

 

$

 

6,920

 

 

$

 

6,997

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basis Point

Gross Profit Margin

 

 

 

 

 

 

 

2019

 

2018

 

Change

Gross profit margin, GAAP

 

 

 

 

 

 

 

 

59.2

%

 

 

59.5

%

 

 

(30

)

Global Growth and Efficiency Program

 

 

 

 

 

 

 

 

0.1

%

 

 

0.1

%

 

 

Gross profit margin, non-GAAP

 

 

 

 

 

 

 

 

59.3

%

 

 

59.6

%

 

 

(30

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, General and Administrative Expenses

 

 

 

 

 

2019

 

2018

 

 

Selling, general and administrative expenses, GAAP

 

 

 

$

 

4,163

 

 

$

 

4,061

 

 

 

Global Growth and Efficiency Program

 

 

 

 

 

 

(42

)

 

 

(24

)

 

 

Selling, general and administrative expenses, non-GAAP

 

 

 

$

 

4,121

 

 

$

 

4,037

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basis Point

Selling, General and Administrative Expenses as a Percentage of Net Sales

 

 

 

2019

 

2018

 

Change

Selling, general and administrative expenses as a percentage of Net sales, GAAP

 

 

 

 

35.6

%

 

 

34.6

%

 

 

100

 

Global Growth and Efficiency Program

 

 

 

 

 

 

(0.3

)%

 

 

(0.2

)%

 

 

Selling, general and administrative expenses as a percentage of Net sales, non-GAAP

 

 

35.3

%

 

 

34.4

%

 

 

90

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other (Income) Expense, Net

 

 

 

 

 

 

 

2019

 

2018

 

 

Other (income) expense, net, GAAP

 

 

 

 

 

$

 

125

 

 

$

 

114

 

 

 

Global Growth and Efficiency Program

 

 

 

 

 

 

(43

)

 

 

(64

)

 

 

Acquisition costs

 

 

 

 

 

 

(18

)

 

 

 

 

Other (income) expense, net, non-GAAP

 

 

 

 

 

$

 

64

 

 

$

 

50

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating Profit

 

 

 

 

 

 

 

2019

 

2018

 

% Change

Operating profit, GAAP

 

 

 

 

 

$

 

2,623

 

 

$

 

2,803

 

 

 

(6

)%

Global Growth and Efficiency Program

 

 

 

 

 

 

94

 

 

 

107

 

 

 

Acquisition costs

 

 

 

 

 

 

18

 

 

 

 

 

Operating profit, non-GAAP

 

 

 

 

 

$

 

2,735

 

 

$

 

2,910

 

 

 

(6

)%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basis Point

Operating Profit Margin

 

 

 

 

 

 

 

2019

 

2018